Technology Innovation, People Centric
Adhering to the mission of providing trustworthy and universal access to state-of-the-art solutions of prolonging and reshaping all lives, Endovastec™ is committed to building a leading enterprise of emerging technologies in great vessel surgery and peripheral vascular medicine.
Products
Endovastec™ focuses on the research and development (R&D), manufacturing, sales and services of aortic, peripheral vascular and tumor intervention devices,and our main products are thoracic and abdominal aortic stent grafts, stent grafts in surgical operation, peripheral vascular stents, drug-coated balloon dilatation catheters, balloon dilatation catheters, vena cava filters and snare retrieval kits etc.
News
Endovastec™ Completes First Implantation of Minos™ in Malaysia
The Minos™ Abdominal Aortic Stent Graft and Delivery System (Minos™), developed by Endovastec™, was recently used in its first post-market implantation in Malaysia.
10 Jun 2025
Endovastec™’s Talos™ Completes First Commercial Use in South America
Endovastec™ is proud to announce the first successful clinical implantation of its Talos™ Thoracic Stent Graft System (Talos™) in South America. The procedure was performed by Prof. Bruna de Fina, Dr. Henrique Elkis, Dr. Guilherme Centofanti, and their team from Samaritano Paulista Hospital in São Paulo, Brazil.
23 May 2025
Endovastec™’s Minos™ Receives CE MDR Certification and Gains Market Approval in Egypt
The Minos™ Abdominal Aortic Stent Graft and Delivery System (Minos™), developed by Endovastec™, recently received CE MDR (Medical Device Regulation (EU) 2017/745) certification and market approval in Egypt - a milestone in its global market expansion.
15 May 2025